Skip to content
Recall Observatory FDA recall evidence

Drug product

Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.

D-0037-2026

September 15, 2025

Class II

Product summary

Firm
Graviti Pharmaceuticals Private Limited
Event
Event 97629
Status
Ongoing
Classification
Class II
Quantity
46,512/30 count bottles
Official record key
drug-enforcement:D-0037-2026

Official wording

Reason: Failed Tablet/Capsule Specifications

Code information: Batch # BPB124341A, Exp date: 10/2026

Distribution pattern: Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed Tablet/Capsule Specifications